摘要心脏移植超急性排斥反应(hyperacute rejection,HAR)与补体系统激活有关,迅速导致移植心脏功能丧失.动物实验中使用眼睛蛇毒因子、可溶性补体受体1、补体调节蛋白以及C5单克隆抗体等补体抑制剂,可以从补体级联反应的不同水平抑制同种或异种心脏移植HAR的发生.抑制补体激活将在临床心脏移植HAR的预防及治疗中显示出重要的作用.
更多相关知识
abstractsHyperacute rejection (HAR) is closely associated with the activation of complements, and results in the failure of heart transplantation. Complement inhibitors, such as cobra venom factor, soluble complement receptor type 1, compstatin, complement regulate proteins and anti-C5 monoclonal antibody, can attenuate or eliminate the destructive effect of HAR in animal model of cardiac allo-or xenotransplantation from different level of complement system. Anti-complement therapy may be a promising strategy to prevent HAR in clinical heart transplantation.
More相关知识
- 浏览0
- 被引2
- 下载0

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



